{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:49:53Z","timestamp":1788544193184,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T00:00:00Z","timestamp":1722124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["22K08482"],"award-info":[{"award-number":["22K08482"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["17K16188"],"award-info":[{"award-number":["17K16188"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["GSE160276"],"award-info":[{"award-number":["GSE160276"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neoplasia"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.neo.2024.101035","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T09:04:39Z","timestamp":1722589479000},"page":"101035","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["PAX5 functions as a tumor suppressor by RB-E2F-mediated cell cycle arrest in Kaposi sarcoma-associated herpesvirus-infected primary effusion lymphoma"],"prefix":"10.1016","volume":"56","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3897-5204","authenticated-orcid":false,"given":"Hiroki","family":"Goto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryusho","family":"Kariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eriko","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5332-4434","authenticated-orcid":false,"given":"Harutaka","family":"Katano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3124-5206","authenticated-orcid":false,"given":"Seiji","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neo.2024.101035_bib0001","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199505043321802","article-title":"Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas","volume":"332","author":"Cesarman","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neo.2024.101035_bib0002","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1182\/blood.V88.2.645.bloodjournal882645","article-title":"Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus","volume":"88","author":"Nador","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.neo.2024.101035_bib0003","doi-asserted-by":"crossref","first-page":"65","DOI":"10.5582\/irdr.2014.01010","article-title":"Current status of treatment for primary effusion lymphoma","volume":"3","author":"Okada","year":"2014","journal-title":"Intractable Rare. Dis. Res."},{"key":"10.1016\/j.neo.2024.101035_bib0004","doi-asserted-by":"crossref","first-page":"4372","DOI":"10.1200\/JCO.2005.07.084","article-title":"Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS","volume":"23","author":"Boulanger","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.neo.2024.101035_bib0005","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/hon.2372","article-title":"Clinical characteristics and survival outcome of primary effusion lymphoma: a review of 105 patients","volume":"35","author":"El-Fattah","year":"2017","journal-title":"Hematol. Oncol."},{"key":"10.1016\/j.neo.2024.101035_bib0006","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1007\/s12185-019-02668-0","article-title":"The current state of human immunodeficiency virus-associated lymphoma in Japan: a nationwide retrospective study of the Japanese society of hematology blood disease registry","volume":"110","author":"Hagiwara","year":"2019","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.neo.2024.101035_bib0007","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1158\/1078-0432.CCR-04-1857","article-title":"Inhibition of phosphatidylinositol 3\u2032-kinase\/AKT signaling promotes apoptosis of primary effusion lymphoma cells","volume":"11","author":"Uddin","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.neo.2024.101035_bib0008","doi-asserted-by":"crossref","first-page":"e39945","DOI":"10.1371\/journal.pone.0039945","article-title":"Cross-talk between NFkB and the PI3-kinase\/AKT pathway can be targeted in primary effusion lymphoma (PEL) cell lines for efficient apoptosis","volume":"7","author":"Hussain","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neo.2024.101035_bib0009","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00432-014-1842-9","article-title":"Targeting VEGF and interleukin-6 for controlling malignant effusion of primary effusion lymphoma","volume":"141","author":"Goto","year":"2015","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.neo.2024.101035_bib0010","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.3324\/haematol.2009.007260","article-title":"Mutational analysis of TP53, PTEN, PIK3CA and CTNNB1\/beta-catenin genes in human herpesvirus 8-associated primary effusion lymphoma","volume":"94","author":"Boulanger","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.neo.2024.101035_bib0011","first-page":"2662","article-title":"The promoter of the CD19 gene is a target for the B-cell-specific transcription factor BSAP","volume":"12","author":"Kozmik","year":"1992","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.neo.2024.101035_bib0012","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/B978-0-12-385991-4.00005-2","article-title":"Pax5: a master regulator of B cell development and leukemogenesis","volume":"111","author":"Medvedovic","year":"2011","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.neo.2024.101035_bib0013","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/nature05690","article-title":"Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia","volume":"446","author":"Mullighan","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.neo.2024.101035_bib0014","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/nature21076","article-title":"Metabolic gatekeeper function of B-lymphoid transcription factors","volume":"542","author":"Chan","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.neo.2024.101035_bib0015","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/hep.24124","article-title":"Paired box gene 5 is a novel tumor suppressor in hepatocellular carcinoma through interaction with p53 signaling pathway","volume":"53","author":"Liu","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.neo.2024.101035_bib0016","doi-asserted-by":"crossref","first-page":"7420","DOI":"10.18632\/oncotarget.1973","article-title":"Applicability of the methylated CpG sites of paired box 5 (PAX5) promoter for prediction the prognosis of gastric cancer","volume":"5","author":"Deng","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.neo.2024.101035_bib0017","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1038\/sj.onc.1206270","article-title":"Disruption of the B-cell specific transcriptional program in HHV-8 associated primary effusion lymphoma cell lines","volume":"22","author":"Arguello","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2024.101035_bib0018","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s12185-013-1339-3","article-title":"Establishment of a CD4-positive cell line from an AIDS-related primary effusion lymphoma","volume":"97","author":"Goto","year":"2013","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.neo.2024.101035_bib0019","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/(SICI)1096-9071(199908)58:4<394::AID-JMV12>3.0.CO;2-H","article-title":"Establishing and characterizing a CD30-positive cell line harboring HHV-8 from a primary effusion lymphoma","volume":"58","author":"Katano","year":"1999","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.neo.2024.101035_bib0020","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF02982580","article-title":"Establishment of a primary effusion lymphoma cell line (RM-P1) and in vivo growth system using SCID mice","volume":"76","author":"Miyagi","year":"2002","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.neo.2024.101035_bib0021","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1016\/j.ejca.2014.03.004","article-title":"Efficacy of anti-CD47 antibody-mediated phagocytosis with macrophages against primary effusion lymphoma","volume":"50","author":"Goto","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.neo.2024.101035_bib0022","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neo.2024.101035_bib0023","doi-asserted-by":"crossref","first-page":"5252","DOI":"10.1038\/onc.2017.138","article-title":"Restoring PU.1 induces apoptosis and modulates viral transactivation via interferon-stimulated genes in primary effusion lymphoma","volume":"36","author":"Goto","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2024.101035_bib0024","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s12185-008-0215-z","article-title":"Early development of human hematopoietic and acquired immune systems in new born NOD\/Scid\/Jak3null mice intrahepatic engrafted with cord blood-derived CD34 + cells","volume":"88","author":"Okada","year":"2008","journal-title":"Int. J. Hematol."},{"key":"10.1016\/j.neo.2024.101035_bib0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0002-9440(10)65097-3","article-title":"High expression of HHV-8-encoded ORF73 protein in spindle-shaped cells of Kaposi's sarcoma","volume":"155","author":"Katano","year":"1999","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neo.2024.101035_bib0026","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1128\/JVI.79.2.1244-1251.2005","article-title":"Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association","volume":"79","author":"Fan","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.neo.2024.101035_bib0027","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/eji.1830270325","article-title":"Pax-5 is identical to EBB-1\/KLP and binds to the VpreB and lambda5 promoters as well as the KI and KII sites upstream of the Jkappa genes","volume":"27","author":"Tian","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.neo.2024.101035_bib0028","first-page":"1716s","article-title":"The partial homeodomain of the transcription factor Pax-5 (BSAP) is an interaction motif for the retinoblastoma and TATA-binding proteins","volume":"59","author":"Eberhard","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.neo.2024.101035_bib0029","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0006-291X(02)02032-6","article-title":"Pax-2 interacts with RB and reverses its repression on the promoter of Rig-1, a Robo member","volume":"296","author":"Yuan","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neo.2024.101035_bib0030","doi-asserted-by":"crossref","first-page":"4824","DOI":"10.1038\/onc.2011.190","article-title":"PAX8 promotes tumor cell growth by transcriptionally regulating E2F1 and stabilizing RB protein","volume":"30","author":"Li","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.neo.2024.101035_bib0031","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.tibs.2004.06.006","article-title":"E2F target genes: unraveling the biology","volume":"29","author":"Bracken","year":"2004","journal-title":"Trends Biochem. Sci"},{"key":"10.1016\/j.neo.2024.101035_bib0032","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3389\/fmicb.2017.00613","article-title":"Reactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus: an update","volume":"8","author":"Aneja","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.neo.2024.101035_bib0033","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1128\/JVI.01742-10","article-title":"Oxidative stress induces reactivation of Kaposi's sarcoma-associated herpesvirus and death of primary effusion lymphoma cells","volume":"85","author":"Li","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.neo.2024.101035_bib0034","doi-asserted-by":"crossref","first-page":"6207","DOI":"10.1128\/JVI.74.13.6207-6212.2000","article-title":"Kaposi's sarcoma-associated herpesvirus open reading frame 50\/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line","volume":"74","author":"Gradoville","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.neo.2024.101035_bib0035","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1093\/hmg\/9.16.2395","article-title":"The DNA methyltransferases of mammals","volume":"9","author":"Bestor","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neo.2024.101035_bib0036","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/0092-8674(90)90015-7","article-title":"High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines","volume":"62","author":"Antequera","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.neo.2024.101035_bib0037","doi-asserted-by":"crossref","first-page":"14554","DOI":"10.1073\/pnas.0604469103","article-title":"Recruitment of the de novo DNA methyltransferase Dnmt3a by Kaposi's sarcoma-associated herpesvirus LANA","volume":"103","author":"Shamay","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neo.2024.101035_bib0038","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1128\/JVI.01997-09","article-title":"Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway","volume":"84","author":"Lu","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.neo.2024.101035_bib0039","doi-asserted-by":"crossref","first-page":"e00008","DOI":"10.1128\/JVI.00008-18","article-title":"Modulation of cellular CpG DNA methylation by Kaposi's sarcoma-associated herpesvirus","volume":"92","author":"Journo","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.neo.2024.101035_bib0040","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/leu.2013.211","article-title":"PAX5 overexpression is not enough to reestablish the mature B-cell phenotype in classical Hodgkin lymphoma","volume":"28","author":"Dimitrova","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.neo.2024.101035_bib0041","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2141.2007.06583.x","article-title":"Loss of bHLH transcription factor E2A activity in primary effusion lymphoma confers resistance to apoptosis","volume":"137","author":"Lietz","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.neo.2024.101035_bib0042","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1073\/pnas.90.15.6914","article-title":"E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product","volume":"90","author":"Flemington","year":"1993","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.neo.2024.101035_bib0043","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0092-8674(95)90385-2","article-title":"The retinoblastoma protein and cell cycle control","volume":"81","author":"Weinberg","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.neo.2024.101035_bib0044","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1101\/gad.10.23.2949","article-title":"The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway","volume":"10","author":"Hofmann","year":"1996","journal-title":"Genes Dev."},{"key":"10.1016\/j.neo.2024.101035_bib0045","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1101\/gad.240416.114","article-title":"Pax5 loss imposes a reversible differentiation block in B-progenitor acute lymphoblastic leukemia","volume":"28","author":"Liu","year":"2014","journal-title":"Genes Dev."},{"key":"10.1016\/j.neo.2024.101035_bib0046","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.4049\/jimmunol.164.9.4672","article-title":"IL-6 receptor independent stimulation of human gp130 by viral IL-6","volume":"164","author":"Mullberg","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.neo.2024.101035_bib0047","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2741\/3322","article-title":"Kaposi's sarcoma-associated herpesvirus ORF57 in viral RNA processing","volume":"14","author":"Majerciak","year":"2009","journal-title":"Front Biosci (Landmark Ed)"}],"container-title":["Neoplasia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558624000770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476558624000770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T03:38:27Z","timestamp":1778816307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476558624000770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":47,"alternative-id":["S1476558624000770"],"URL":"https:\/\/doi.org\/10.1016\/j.neo.2024.101035","relation":{},"ISSN":["1476-5586"],"issn-type":[{"value":"1476-5586","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PAX5 functions as a tumor suppressor by RB-E2F-mediated cell cycle arrest in Kaposi sarcoma-associated herpesvirus-infected primary effusion lymphoma","name":"articletitle","label":"Article Title"},{"value":"Neoplasia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neo.2024.101035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101035"}}